Tekijä VIII (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tekijä VIII" in Finnish language version.

refsWebsite

Global rank Finnish rank

4^th place

12^th place

5^th place

9^th place

2^nd place

10^th place

doi.org

S Palta, R Saroa, A Palta: Overview of the coagulation system. Indian Journal of Anaesthesia, 2014, 58. vsk, nro 5, s. 515–523. PubMed:25535411. doi:10.4103/0019-5049.144643. ISSN 0019-5049. Artikkelin verkkoversio.
M Zhuang et al: Dihydrodiosgenin inhibits endothelial cell-derived factor VIII and platelet-mediated hepatocellular carcinoma metastasis. Cancer Management and Research, 2019, 11. vsk, s. 4871–4882. PubMed:31239763. doi:10.2147/CMAR.S202225. ISSN 1179-1322. Artikkelin verkkoversio.
CE Marcucci et al: Perioperative hemostasis: coagulation for anesthesiologists, s. 193. Springer-Verlag, 2015. ISBN 9783642550041. doi:10.1007/978-3-642-55004-1.
K Lieuw: Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches? Journal of Blood Medicine, 2017, 8. vsk, s. 67–73. PubMed:28670147. doi:10.2147/JBM.S103796. ISSN 1179-2736. Artikkelin verkkoversio.
C Zheng, B Zhang: Combined deficiency of coagulation factors V and VIII: an update. Seminars in thrombosis and hemostasis, 2013, 39. vsk, nro 6, s. 613–620. PubMed:23852824. doi:10.1055/s-0033-1349223. ISSN 0094-6176. Artikkelin verkkoversio.

S Palta, R Saroa, A Palta: Overview of the coagulation system. Indian Journal of Anaesthesia, 2014, 58. vsk, nro 5, s. 515–523. PubMed:25535411. doi:10.4103/0019-5049.144643. ISSN 0019-5049. Artikkelin verkkoversio.
NA Orlova et al: Blood clotting factor VIII: from evolution to therapy. Acta Naturae, 2013, 5. vsk, nro 2, s. 19–39. PubMed:23819034. ISSN 2075-8251. Artikkelin verkkoversio.
M Zhuang et al: Dihydrodiosgenin inhibits endothelial cell-derived factor VIII and platelet-mediated hepatocellular carcinoma metastasis. Cancer Management and Research, 2019, 11. vsk, s. 4871–4882. PubMed:31239763. doi:10.2147/CMAR.S202225. ISSN 1179-1322. Artikkelin verkkoversio.
H Mansouritorghabeh: Clinical and laboratory approaches to hemophilia A. Iranian Journal of Medical Sciences, 2015, 40. vsk, nro 3, s. 194–205. PubMed:25999618. ISSN 0253-0716. Artikkelin verkkoversio.
K Lieuw: Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches? Journal of Blood Medicine, 2017, 8. vsk, s. 67–73. PubMed:28670147. doi:10.2147/JBM.S103796. ISSN 1179-2736. Artikkelin verkkoversio.
C Zheng, B Zhang: Combined deficiency of coagulation factors V and VIII: an update. Seminars in thrombosis and hemostasis, 2013, 39. vsk, nro 6, s. 613–620. PubMed:23852824. doi:10.1055/s-0033-1349223. ISSN 0094-6176. Artikkelin verkkoversio.

S Palta, R Saroa, A Palta: Overview of the coagulation system. Indian Journal of Anaesthesia, 2014, 58. vsk, nro 5, s. 515–523. PubMed:25535411. doi:10.4103/0019-5049.144643. ISSN 0019-5049. Artikkelin verkkoversio.
NA Orlova et al: Blood clotting factor VIII: from evolution to therapy. Acta Naturae, 2013, 5. vsk, nro 2, s. 19–39. PubMed:23819034. ISSN 2075-8251. Artikkelin verkkoversio.
M Zhuang et al: Dihydrodiosgenin inhibits endothelial cell-derived factor VIII and platelet-mediated hepatocellular carcinoma metastasis. Cancer Management and Research, 2019, 11. vsk, s. 4871–4882. PubMed:31239763. doi:10.2147/CMAR.S202225. ISSN 1179-1322. Artikkelin verkkoversio.
H Mansouritorghabeh: Clinical and laboratory approaches to hemophilia A. Iranian Journal of Medical Sciences, 2015, 40. vsk, nro 3, s. 194–205. PubMed:25999618. ISSN 0253-0716. Artikkelin verkkoversio.
K Lieuw: Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches? Journal of Blood Medicine, 2017, 8. vsk, s. 67–73. PubMed:28670147. doi:10.2147/JBM.S103796. ISSN 1179-2736. Artikkelin verkkoversio.
C Zheng, B Zhang: Combined deficiency of coagulation factors V and VIII: an update. Seminars in thrombosis and hemostasis, 2013, 39. vsk, nro 6, s. 613–620. PubMed:23852824. doi:10.1055/s-0033-1349223. ISSN 0094-6176. Artikkelin verkkoversio.

S Palta, R Saroa, A Palta: Overview of the coagulation system. Indian Journal of Anaesthesia, 2014, 58. vsk, nro 5, s. 515–523. PubMed:25535411. doi:10.4103/0019-5049.144643. ISSN 0019-5049. Artikkelin verkkoversio.
NA Orlova et al: Blood clotting factor VIII: from evolution to therapy. Acta Naturae, 2013, 5. vsk, nro 2, s. 19–39. PubMed:23819034. ISSN 2075-8251. Artikkelin verkkoversio.
M Zhuang et al: Dihydrodiosgenin inhibits endothelial cell-derived factor VIII and platelet-mediated hepatocellular carcinoma metastasis. Cancer Management and Research, 2019, 11. vsk, s. 4871–4882. PubMed:31239763. doi:10.2147/CMAR.S202225. ISSN 1179-1322. Artikkelin verkkoversio.
H Mansouritorghabeh: Clinical and laboratory approaches to hemophilia A. Iranian Journal of Medical Sciences, 2015, 40. vsk, nro 3, s. 194–205. PubMed:25999618. ISSN 0253-0716. Artikkelin verkkoversio.
K Lieuw: Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches? Journal of Blood Medicine, 2017, 8. vsk, s. 67–73. PubMed:28670147. doi:10.2147/JBM.S103796. ISSN 1179-2736. Artikkelin verkkoversio.
C Zheng, B Zhang: Combined deficiency of coagulation factors V and VIII: an update. Seminars in thrombosis and hemostasis, 2013, 39. vsk, nro 6, s. 613–620. PubMed:23852824. doi:10.1055/s-0033-1349223. ISSN 0094-6176. Artikkelin verkkoversio.